SCHEMBL26683089

SCHEMBL26683089

O=Cc1cc(-c2cccc(O)c2)cc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.44
HSD17B1 P14061 9/20 0.43
HSD17B2 P37059 9/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
P2RX1 P51575 1/20 0.40
KDM1A O60341 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
P4HB P07237 1/20 0.39
TRIM24 O15164 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
ERN1 O75460 1/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
BAZ1A Q9NRL2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30541278 0.82 KIF11 (0.48) TRIM24TRIM33
SCHEMBL1976815 0.82 TRIM24 (0.47) TRIM24TRIM33
SCHEMBL17829926 0.82 KIF11 (0.48) TRIM24TRIM33
SCHEMBL26682561 0.81 AURKA (0.41) ARHSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL1029849 0.78 HSD17B1 (0.58) ARHSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL7886087 0.78 HSD17B1 (0.58) HSD17B1HSD17B2CYP3A4CYP2C9KDM1A
SCHEMBL26681988 0.78 ERN1 (0.36) HSD17B1KDM1AERN1
SCHEMBL18001843 0.77 RXRA (0.44) TRIM24TRIM33
SCHEMBL16398658 0.77 KIF11 (0.41) KDM1A
SCHEMBL26824259 0.76 HSD17B1 (0.47) ARHSD17B1HSD17B2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-25 US disclosed
EP-4279476-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP MGMT, MCL1, FANCF AR 2894/4885HSD17B1 2694/4885HSD17B2 2476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.